MiMedx Group (NASDAQ:MDXG) reported quarterly losses of $(0.07) per share which missed the analyst consensus estimate of $(0.03) by 133.33 percent. This is a 216.67 percent decrease over earnings of $0.06 per share from the same period last year. The company reported quarterly sales of $58.991 million which missed the analyst consensus estimate of $65.020 million by 9.27 percent. This is a 33.12 percent decrease over sales of $88.205 million the same period last year.